This inventor holds 3 USPTO granted patents. Top assignee: Natco Pharma Limited. Active years: 2022-2023.
Company Filing History:
Years Active: 2022-2023
Title: Bhat Pavan: Innovator in Pharmaceutical Compositions
Introduction
Bhat Pavan is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, holding a total of 3 patents. His work focuses on developing stable pharmaceutical compositions that enhance the efficacy of various medications.
Latest Patents
Bhat Pavan's latest patents include innovative formulations that address critical medical needs. One of his notable inventions is a stable pharmaceutical composition comprising trifluridine and tipiracil hydrochloride. This invention relates to a tablet composition that includes these active ingredients along with one or more pharmaceutically acceptable excipients, along with a process for preparing such compositions. Another significant patent involves pharmaceutical compositions comprising Ibrutinib, which also focuses on a tablet composition that includes Ibrutinib and one or more pharmaceutically acceptable excipients, along with the process for their preparation.
Career Highlights
Bhat Pavan is associated with Natco Pharma Limited, a prominent player in the pharmaceutical industry. His work at Natco Pharma has allowed him to contribute to the development of innovative drug formulations that aim to improve patient outcomes.
Collaborations
Bhat Pavan has collaborated with several talented individuals in his field, including Bhavanasi Krishna Murthy and Nannapaneni Venkaiah Chowdary. These collaborations have fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.
Conclusion
Bhat Pavan's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare through effective drug formulations. His patents reflect a deep understanding of pharmaceutical science and a dedication to advancing medical treatments.